Ademi LLP is investigating whether the proposed acquisition of Surgery Partners (NYSE: SGRY) by HealthSpan, provides fair value to Surgery Partners’ public shareholders and whether Surgery Partners’ Board adequately protected shareholder interests in negotiating and approving the transaction.
What Is Ademi LLP Investigating?
- The exchange ratio and whether it adequately reflects Surgery Partners’ value and future prospects;
- Substantial change-of-control benefits available to Surgery Partners insiders in connection with the transaction;
- Restrictions on competing transactions, including a significant termination penalty that may discourage another potential buyer from making a superior proposal; and
- The conduct of Surgery Partners’ Board of Directors in negotiating and approving the transaction and whether the Board fulfilled its duties to public shareholders.